A recent study reveals that integrating Artificial Intelligence (AI) into colon cancer diagnosis over the past five years has ...

CNW/ - Syantra, Inc., a biotechnology company revolutionizing cancer detection, is announcing Scottsdale, Arizona based ...

The next breakthrough in cancer screening is emerging from the convergence of artificial intelligence and canine biology. That’s the thesis behind SpotitEarly, a startup that recently launched in the ...

The study will evaluate the performance of Syantra's blood-based Onco-ID Breast molecular assay for screening women at elevated risk of breast cancer.

Galleri is a blood test that aims to detect over 50 types of cancer early. It analyzes cell-free DNA (cfDNA) and methylation patterns to identify potential cancer signals. The test is intended for ...

FANSS study data presented at ESMO Asia 2025 demonstrate the feasibility of screening Asian women who do not smokePALO ALTO, Calif., Dec. 5, 2025 /PRNewswire/ -- DELFI Diagnostics, Inc., developer of ...

A new research paper featured on the cover of Volume 17, Issue 11 of Aging-US was published on October 30, 2025, titled "SAMP ...

The tool SAMP-Score has already screened 10,000 compounds and found one that safely forces stubborn, treatment-resistant ...

Cancer continues to be one of the world's top causes of death, partly because of delayed discovery of the disease. But according to a recently released study, a simple blood test may be able to ...